CHEK2 and cancer: As reported in several studies, it is evident that the contribution of CHEK2 1100delC mutation to the burden of cancer varies according to the ethnic group, and from country to country (Antoni et al. 2007; Gonzalez-Hormazabal et al. 2008; Martınez-Bouzas et al. 2007) (Table 2).